Xcout IntelSign inSubscribe

PGxAI competitors & alternatives

Decision/Risk Analysis

Founded in 2023 and backed by ATEM Capital, PGxAI operates an AI-powered pharmacogenetics platform focused on precision medicine. The company combines proprietary algorithms and…

See who competes with PGxAI

Ranked competitors and alternatives for this company are available inside Xcout Intel. Subscribe to open it.

Subscribe to see PGxAI →Already a subscriber? Sign in

Xcout Intel tracks PGxAI continuously — this profile deepens as new filings, funding, people and hiring data arrive.